Novavax Inc (NASDAQ:NVAX)

12.02
Delayed Data
As of 4:00pm ET
 +0.78 / +6.94%
Today’s Change
8.75
Today|||52-Week Range
101.39
+16.93%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$960.2M

Company Description

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Contact Information

Novavax, Inc.
21 Firstfield Road
Gaithersburg Maryland 20878
P:(240) 268-2000
Investor Relations:

Employees

Shareholders

Mutual fund holders25.03%
Other institutional19.99%
Individual stakeholders0.29%

Top Executives

John C.s JacobsPresident, Chief Executive Officer & Director
Richard CrowleyChief Operating Officer & Executive Vice President
James Patrick KellyChief Financial Officer, Treasurer & Executive VP
Gale E. SmithChief Scientist & Senior Vice President-Discovery
Gregory M. GlennPresident-Research & Development